JPS5479296A - Xanthine derivative - Google Patents

Xanthine derivative

Info

Publication number
JPS5479296A
JPS5479296A JP12573978A JP12573978A JPS5479296A JP S5479296 A JPS5479296 A JP S5479296A JP 12573978 A JP12573978 A JP 12573978A JP 12573978 A JP12573978 A JP 12573978A JP S5479296 A JPS5479296 A JP S5479296A
Authority
JP
Japan
Prior art keywords
xanthine derivative
xanthine
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP12573978A
Other languages
English (en)
Inventor
Hookan Akuseru Magunusu Suten
Gunnaa Chierurin Peru
Giyoran Augusuto Peruson Kaaru
Magunusu Serenbiyuu Rarusu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Draco AB
Original Assignee
Draco AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco AB filed Critical Draco AB
Publication of JPS5479296A publication Critical patent/JPS5479296A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP12573978A 1977-10-14 1978-10-14 Xanthine derivative Pending JPS5479296A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7711581A SE416810C (sv) 1977-10-14 1977-10-14 Forfarande for framstellning av xantinderivat med antiallergisk aktivitet

Publications (1)

Publication Number Publication Date
JPS5479296A true JPS5479296A (en) 1979-06-25

Family

ID=20332576

Family Applications (1)

Application Number Title Priority Date Filing Date
JP12573978A Pending JPS5479296A (en) 1977-10-14 1978-10-14 Xanthine derivative

Country Status (21)

Country Link
US (1) US4233303A (ja)
EP (1) EP0001735B1 (ja)
JP (1) JPS5479296A (ja)
AT (1) AT363491B (ja)
AU (1) AU521585B2 (ja)
CA (1) CA1109470A (ja)
CS (1) CS208756B2 (ja)
DD (1) DD139855A5 (ja)
DE (1) DE2862017D1 (ja)
DK (1) DK148260C (ja)
FI (1) FI66383C (ja)
HK (1) HK6385A (ja)
HU (1) HU180219B (ja)
IE (1) IE47884B1 (ja)
IT (1) IT1109208B (ja)
NO (1) NO147562C (ja)
NZ (1) NZ188566A (ja)
SE (1) SE416810C (ja)
SG (1) SG85584G (ja)
SU (1) SU755199A3 (ja)
ZA (1) ZA785335B (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56166191A (en) * 1980-04-18 1981-12-21 Draco Ab 3,8-dialkylxanthines and manufacture
EP0619316A1 (en) * 1993-04-07 1994-10-12 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivatives
US7579331B2 (en) 2003-04-25 2009-08-25 Novacardia, Inc. Method of improved diuresis in individuals with impaired renal function

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7810947L (sv) * 1978-10-20 1980-04-21 Draco Ab 3-alkylxanthines
US4755517A (en) * 1986-07-31 1988-07-05 Warner-Lambert Company Derivatives of xanthine, pharmaceutical compositions and methods of use therefor
US5298508A (en) * 1988-07-19 1994-03-29 The United States Of America As Represented By The Department Of Health And Human Services Irreversible inhibitors of adenosine receptors
US5321029A (en) * 1988-11-14 1994-06-14 Beecham-Wuelfing Gmbh & Co.K.G. Xanthines
GB8826595D0 (en) * 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
IT1229195B (it) * 1989-03-10 1991-07-25 Poli Ind Chimica Spa Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche.
GB8929208D0 (en) * 1989-12-27 1990-02-28 Almirall Lab New xanthine derivatives
US5047534A (en) * 1990-03-26 1991-09-10 Merrell Dow Pharmaceuticals Inc. Selective adenosine receptor agents
US5342841A (en) * 1992-03-12 1994-08-30 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivatives
US5366977A (en) * 1992-09-29 1994-11-22 The United States Of America, As Represented By The Department Of Health And Human Services Method of treating cystic fibrosis using 8-cyclopentyl-1,3-dipropylxanthine or xanthine amino congeners
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5661153A (en) * 1994-07-19 1997-08-26 Japan Energy Corporation 1-arylpyrimidine derivatives and pharmaceutical use thereof
ATE247655T1 (de) * 1994-12-13 2003-09-15 Euro Celtique Sa Dreifachsubstituierte thioxanthine
WO1996018399A1 (en) * 1994-12-13 1996-06-20 Euro-Celtique, S.A. Aryl thioxanthines
US6166041A (en) * 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) * 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) * 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
BRPI0509753A (pt) * 2004-04-16 2007-10-16 Novacardia Inc composição farmacêutica e método de tratamento de doença cardiovascular
US20070049757A1 (en) * 2005-08-26 2007-03-01 Rieger Jayson M Methods for the synthesis of substituted amino uracils

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2713389A1 (de) * 1976-03-31 1977-10-13 Cooper Lab Neuartige xanthinverbindungen und dieselben enthaltende pharmazeutische zubereitung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1911279A1 (de) * 1969-03-05 1970-11-12 Eckert Dr Theodor Verfahren zur Erhoehung der Resorptionsfaehigkeit von Arzneistoffen
US3900474A (en) * 1973-05-14 1975-08-19 Kendall & Co Trifluoroalkyl, fluorobenzyl, pentafluorobenzyl, fluorobenzenesulfonyl, and pentafluorobenzenesulfonyl theophyllines
US4061753A (en) * 1976-02-06 1977-12-06 Interx Research Corporation Treating psoriasis with transient pro-drug forms of xanthine derivatives
US4120947A (en) * 1976-03-31 1978-10-17 Cooper Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2713389A1 (de) * 1976-03-31 1977-10-13 Cooper Lab Neuartige xanthinverbindungen und dieselben enthaltende pharmazeutische zubereitung

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56166191A (en) * 1980-04-18 1981-12-21 Draco Ab 3,8-dialkylxanthines and manufacture
EP0619316A1 (en) * 1993-04-07 1994-10-12 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivatives
US7579331B2 (en) 2003-04-25 2009-08-25 Novacardia, Inc. Method of improved diuresis in individuals with impaired renal function

Also Published As

Publication number Publication date
NO783471L (no) 1979-04-18
IE782041L (en) 1979-04-14
IT1109208B (it) 1985-12-16
CS208756B2 (en) 1981-09-15
HK6385A (en) 1985-02-01
NO147562C (no) 1983-05-18
SU755199A3 (en) 1980-08-07
FI66383C (fi) 1984-10-10
SE416810C (sv) 1982-07-19
IE47884B1 (en) 1984-07-11
EP0001735B1 (en) 1982-09-01
CA1109470A (en) 1981-09-22
DK453778A (da) 1979-04-15
ATA714478A (de) 1980-09-15
EP0001735A1 (en) 1979-05-02
AU521585B2 (en) 1982-04-22
DK148260C (da) 1986-02-10
DE2862017D1 (en) 1982-10-28
IT7851499A0 (it) 1978-10-13
HU180219B (en) 1983-02-28
DD139855A5 (de) 1980-01-23
ZA785335B (en) 1979-09-26
FI783126A (fi) 1979-04-15
DK148260B (da) 1985-05-20
SG85584G (en) 1985-06-07
FI66383B (fi) 1984-06-29
SE416810B (sv) 1981-02-09
AU4036578A (en) 1980-04-17
NZ188566A (en) 1984-07-06
US4233303A (en) 1980-11-11
SE7711581L (sv) 1979-04-15
AT363491B (de) 1981-08-10
NO147562B (no) 1983-01-24

Similar Documents

Publication Publication Date Title
JPS5390251A (en) Hexahydroterphenyl derivative
JPS5479296A (en) Xanthine derivative
AU4113878A (en) 1-alkanoyl-proline derivatives
GB2003876B (en) Beta-haloethylamine derivatives
GB1557019A (en) Metalsulphonamido-benzamide derivatives
EG13665A (en) 2-imino-imidazolidine derivatives
JPS5492974A (en) 44aminoquinoline derivative
JPS5398993A (en) Oxadiazoropyrimidine derivative
AU3888578A (en) 4-hydroxy-2-benzimidazolinone derivatives
JPS5448751A (en) 255alkylcholesterol derivative
JPS5398992A (en) Oxadiazoropyrimidine derivative
GB2009150A (en) Tetrahydrophtalamide derivatives
GB2005261B (en) 2-oxazolydone derivatives
JPS543030A (en) Trioxyacylophenone derivative
JPS53108935A (en) 22hydroxyynnpropylamine derivative
GB2003479B (en) 3-amino-17alpha-aza-d-homoandrostane derivatives
AU3313978A (en) Everninomicin derivatives
GB2000769B (en) 4 - homoisotwistane derivatives
GB2000128B (en) 15-substituted-omega-pentanorprostaglandin derivatives
JPS5424884A (en) Tetrahydroosstriazinethione derivative
JPS5432495A (en) Benzoobisthiazole derivative
JPS53105486A (en) Pyridyllpiperazine derivative
GB2008119B (en) Arylsteroid derivatives
JPS5444651A (en) Diisubstituteddindene derivative
JPS53149995A (en) Curabalanic derivative